Document Detail


How many atrial fibrillation ablation candidates have an underlying supraventricular tachycardia previously unknown? Efficacy of isolated triggering arrhythmia ablation.
MedLine Citation:
PMID:  20833693     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
AIMS: Supraventricular tachycardia may trigger atrial fibrillation (AF). The aim of the study was to evaluate the prevalence of supraventricular tachycardia (SVT) inducibility in patients referred for AF ablation and to evaluate the effects of SVT ablation on AF recurrences.
METHODS AND RESULTS: Two hundred and fifty-seven patients (185 males; mean age: 53.4 ± 14.6 years) referred for AF ablation were studied. In all patients only AF relapses had been documented in the clinical history. Twenty-six patients (10.1%; mean age: 43.4 ± 13.3 years; 17 males) had inducible SVT during electrophysiological study and underwent an ablation targeted only at SVT suppression. Ablation was successful in all 26 patients. The ablative procedures are: 12 slow-pathway ablations for atrioventricular nodal re-entrant tachycardia; 9 concealed accessory pathway ablations for atrioventricular re-entrant tachycardia; and 5 focal ectopic atrial tachycardia ablations. No recurrences of SVT were observed during the follow-up (21 ± 11 months). Two patients (7.7%) showed recurrence of at least one episode of AF. Patients with inducible SVT had less structural heart disease and were younger than those without inducible SVT (interventricular septum thickness: 8.4 ± 1.6 vs. 11.0 ± 1.4 mm, P < 0.01; left atrial diameter: 37.0 ± 3.0 vs. 44.0 ± 2.2 mm, P < 0.01; age: 43.4 ± 13.3 vs. 57.3 ± 11.2 years, P < 0.01). Prevalence of paroxysmal AF was higher in patients with inducible SVT when compared with those with only AF (84.6 vs. 24.6%, P < 0.01).
CONCLUSION: A significant proportion of candidates to AF ablation are inducible for a SVT. SVT ablation showed a preventive effect on AF recurrences. Those patients should be selected for simpler ablation procedures tailored only on the triggering arrhythmia suppression.
Authors:
Luigi Sciarra; Marco Rebecchi; Ermenegildo De Ruvo; Lucia De Luca; Lorenzo Maria Zuccaro; Alessandro Fagagnini; Leonardo Corò; Giuseppe Allocca; Ernesto Lioy; Pietro Delise; Leonardo Calò
Related Documents :
21172733 - Serum c-reactive protein and lipid hydroperoxides in predicting short-term clinical out...
9604243 - Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrilla...
620383 - Detection and pathogenesis of visceral calcification in dialysis patients and patients ...
Publication Detail:
Type:  Journal Article     Date:  2010-09-10
Journal Detail:
Title:  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology     Volume:  12     ISSN:  1532-2092     ISO Abbreviation:  Europace     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883649     Medline TA:  Europace     Country:  England    
Other Details:
Languages:  eng     Pagination:  1707-12     Citation Subset:  IM    
Affiliation:
Cardiology Department, Via Montaione 20 00139, Policlinico Casilino, Rome, Italy. lui.sciarra@libero.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: ...
Next Document:  Insight into Evolution of Bordetella pertussis from Comparative Genomic Analysis: Evidence of Vaccin...